Recent Advances in Biomaterials for Cancer Therapy
A special issue of Journal of Functional Biomaterials (ISSN 2079-4983). This special issue belongs to the section "Biomaterials for Cancer Therapies".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 43
Special Issue Editors
Interests: drug delivery systems; targeted drug delivery system; theranostics; inclusion complex; inorganic nanoparticles; nano emulsions/suspensions
Special Issue Information
Dear Colleagues,
Cancer remains a major global health challenge, with its complexity and adaptability demanding innovative therapeutic approaches. Recent years have witnessed remarkable progress in the development of biomaterials for cancer therapy, leveraging nanotechnology, biomimetic design and targeted delivery strategies. These advancements hold immense potential to revolutionize cancer treatment.
This Special Issue of the Journal of Functional Biomaterials aims to showcase cutting-edge advances in the field of biomaterials for cancer therapy. It provides a platform to explore the tremendous potential of engineered nanoparticles, biomimetic materials and targeted delivery systems in combating cancer's complexity and improving therapeutic outcomes.
We welcome original research articles and comprehensive review articles focused on the following themes (but not limited to):
- Polymeric micelles for the delivery of poorly water-soluble chemotherapeutics;
- Drug-loaded extracellular vesicles for cancer treatment;
- Multistage nanocarriers for the sequential delivery of drug combinations;
- Ultra-small nanoparticles for deep tumor penetration and metastasis targeting;
- Activatable theranostic nanoparticles for imaging and treating minimal residual disease;
- Mechanistic modeling of targeted therapies using PBPK or QSP models;
- Organ-on-chip systems in cancer modeling research;
- Targeted delivery of immunotherapeutic agents;
- Surface-engineered nanocarriers for cancer management;
- Preclinical and clinical studies on biomaterials for cancer therapy.
We look forward to receiving your valuable contributions to this exciting Special Issue.
Dr. Sandeep Urandur
Dr. Venkatesh Teja Banala
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Functional Biomaterials is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- biomaterials
- cancer
- drug delivery
- nanotechnology
- targeted therapy
- theranostics
- immunotherapy
- modeling
- organ-on-chip
- preclinical and clinical studies
